Purpose: This study aimed to identify Type D personality, cancer stigma, symptom experience, and quality of life among lung cancer patients and the factors affecting the relationship between them.
It also aimed to use basic data for the development of an effective nursing intervention program.
Methods: This technical correlation study included 136 patients diagnosed with lung cancer who were being treated in the outpatient respiratory department at the university hospital.
Type D personality, cancer stigma, and symptom experience were assessed and measured using Korean versions of the Type D Scale-14 (DS14), Cataldo Lung Stigma Scale (CLCSS), and MD Anderson Symptom Inventory Lung Cancer Module for lung cancer (MDASI-LC), respectively. Quality of life was measured through a questionnaire survey using the Korean version of the Functional Assessment of Cancer Therapy Scale-General (FACT-G). Data were analyzed using descriptive statistics, independent t-test, χ²-test, Fisher’s exact test, one-way ANOVA, ANCOVA, Pearson’s correlation coefficient, and hierarchical regression analysis using SPSS software version 25.0 for Windows.
Results: The mean scores of Type D personality, cancer stigma, symptom experience, and quality of life were 31.48 points (range, 0–56), 54.79 points (range, 31−124), 67.47 points (range, 0−220), and 66.68 points (range, 0−108), respectively. Hierarchical multiple regression showed that Type D personality, cancer stigma, and symptom experience could explain 57.2% of the variance in quality of life.
Conclusion: Type D personality was found to have the largest influence on quality of life. Healthcare professionals should assess patients' Type D personality and develop patient-tailored Type D personality management programs. Interventions for relieving Type D personality should be developed, and social support and coping strategies of lung cancer survivors should be considered in oncology clinical settings.
Purpose: This study aimed to identify Type D personality, cancer stigma, symptom experience, and quality of life among lung cancer patients and the factors affecting the relationship between them.
It also aimed to use basic data for the development of an effective nursing intervention program.
Methods: This technical correlation study included 136 patients diagnosed with lung cancer who were being treated in the outpatient respiratory department at the university hospital.
Type D personality, cancer stigma, and symptom experience were assessed and measured using Korean versions of the Type D Scale-14 (DS14), Cataldo Lung Stigma Scale (CLCSS), and MD Anderson Symptom Inventory Lung Cancer Module for lung cancer (MDASI-LC), respectively. Quality of life was measured through a questionnaire survey using the Korean version of the Functional Assessment of Cancer Therapy Scale-General (FACT-G). Data were analyzed using descriptive statistics, independent t-test, χ²-test, Fisher’s exact test, one-way ANOVA, ANCOVA, Pearson’s correlation coefficient, and hierarchical regression analysis using SPSS software version 25.0 for Windows.
Results: The mean scores of Type D personality, cancer stigma, symptom experience, and quality of life were 31.48 points (range, 0–56), 54.79 points (range, 31−124), 67.47 points (range, 0−220), and 66.68 points (range, 0−108), respectively. Hierarchical multiple regression showed that Type D personality, cancer stigma, and symptom experience could explain 57.2% of the variance in quality of life.
Conclusion: Type D personality was found to have the largest influence on quality of life. Healthcare professionals should assess patients' Type D personality and develop patient-tailored Type D personality management programs. Interventions for relieving Type D personality should be developed, and social support and coping strategies of lung cancer survivors should be considered in oncology clinical settings.
주제어
#Neoplasms stigma symptom experience D type personality quality of life lung cancer
※ AI-Helper는 부적절한 답변을 할 수 있습니다.